Top Markets
Coin of the day
NutraLife BioSciences, Inc. NutraLife BioSciences, Inc.

NutraLife BioSciences, Inc.

NLBS
Ранг среди акций #41573
NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in... NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products. The company's CBD portfolio is comprehensive, featuring cannabinoid-rich hemp oil sourced from industrial hemp, tinctures, and a variety of topical solutions like lotions and oils designed for direct skin application to alleviate pain or inflammation. Their CBD offerings also extend to face creams, massage oils, nutraceutical sprays enhanced with CBD, and specialized products for pets. In addition to its CBD range, NutraLife BioSciences also manufactures skincare items and hand sanitizers. Customers can acquire the company's products directly from its website, nutralifebiosciences.com, or through a network of private label distributors, other online retailers, and traditional brick-and-mortar stores. Established in 2010 and based in Coconut Creek, Florida, the enterprise was previously known as NutraFuels, Inc. It officially adopted its current name, NutraLife BioSciences, Inc., in March 2019.
Цена акции
$0.0001
Последняя синхронизация: 2024-12-11
Рыночная капитализация
$16.04K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля NutraLife BioSciences, Inc. (NLBS)

Категория

EPS для NutraLife BioSciences, Inc. (NLBS)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций NutraLife BioSciences, Inc., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании NutraLife BioSciences, Inc. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов